Atlas Trials

Spontaneous Retinal Artery Pulses (SPARs) as a Prognostic Determinant of Central Retinal Vein Occlusions (CRVO) in Patients With or Without Intravitreal Aflibercept Injections

Clinical trial NCT04793100 · COMPLETED

Trial details

NCT number
NCT04793100
Sponsor
Fondation Ophtalmologique Adolphe de Rothschild
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Central Retinal Vein Occlusion
Start date
2021-03-24
Primary completion
2025-03-17
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.